abstract |
The present invention relates to 18-methyl-6,7-methylene-17-pregn-4-ene-21,17beta-carbolactones of the general formula (I) where the 6,7-methylene group may be in the alpha or beta position, to pharmaceutical preparations comprising at least one isomer of the formula (I) and to the use thereof in the treatment of endometriosis. |